1-193069322-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001173524.2(RO60):​c.268G>C​(p.Glu90Gln) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

RO60
NM_001173524.2 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.02
Variant links:
Genes affected
RO60 (HGNC:11313): (Ro60, Y RNA binding protein) Enables RNA binding activity. Involved in cellular response to interferon-alpha and regulation of gene expression. Located in cytosol and nucleoplasm. Part of ribonucleoprotein complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19220158).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RO60NM_001173524.2 linkc.268G>C p.Glu90Gln missense_variant 2/9 ENST00000400968.7 NP_001166995.1 P10155-1A0A024R983

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RO60ENST00000400968.7 linkc.268G>C p.Glu90Gln missense_variant 2/91 NM_001173524.2 ENSP00000383752.2 P10155-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 27, 2024The c.268G>C (p.E90Q) alteration is located in exon 2 (coding exon 1) of the TROVE2 gene. This alteration results from a G to C substitution at nucleotide position 268, causing the glutamic acid (E) at amino acid position 90 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.14
T;T;.;.;.;T;.
Eigen
Benign
0.098
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
.;.;D;D;D;D;D
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.19
T;T;T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.2
L;L;L;L;L;L;.
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.83
N;N;N;N;N;N;N
REVEL
Benign
0.15
Sift
Benign
0.19
T;T;T;T;T;T;T
Sift4G
Benign
0.21
T;T;T;T;T;T;T
Polyphen
0.30
B;B;.;.;.;B;.
Vest4
0.51
MutPred
0.49
Loss of ubiquitination at K88 (P = 0.0618);Loss of ubiquitination at K88 (P = 0.0618);Loss of ubiquitination at K88 (P = 0.0618);Loss of ubiquitination at K88 (P = 0.0618);Loss of ubiquitination at K88 (P = 0.0618);Loss of ubiquitination at K88 (P = 0.0618);.;
MVP
0.36
MPC
0.15
ClinPred
0.69
D
GERP RS
5.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.25
gMVP
0.40

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-193038452; API